ArticleScientific reports2025

Pharmacovigilance analysis of immune checkpoint inhibitor-related reproductive adverse effects based on the FDA adverse event reporting system.

Bahadır Köylü et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.